Alpheus Medical, Inc. — Form D/A

Alpheus Medical, Inc. of Chanhassen, MN, a company, filed a Form D amendment with the SEC on 2026-07-30. The offering totals $67.0M, of which $60.5M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (25)

NameRoleLocation
Vijay AgarwalRelated PersonChanhassen, MN
Imran EbaRelated PersonChanhassen, MN
John JohnsonRelated PersonChanhassen, MN
Jeremy LingRelated PersonChanhassen, MN
Juan-Pablo MasRelated PersonChanhassen, MN
Robert SteinRelated PersonChanhassen, MN
Peter ThompsonRelated PersonChanhassen, MN
Klaus VeitingerRelated PersonChanhassen, MN
Steve WeinerRelated PersonChanhassen, MN
Juan-Pablo MasDirectorChanhassen, MN
Klaus VeitingerDirectorChanhassen, MN
Peter ThompsonDirectorChanhassen, MN
Imran EbaDirectorChanhassen, MN
Imran EbaExecutive OfficerChanhassen, MN
Conrad WangDirectorChanhassen, MN
Jeremy LingExecutive OfficerChanhassen, MN
Robert SteinDirectorChanhassen, MN
Steve WeinerExecutive OfficerChanhassen, MN
Vijay AgarwalDirectorChanhassen, MN
Vijay AgarwalExecutive OfficerChanhassen, MN
Aaron SandoskiDirectorBedford, MA
Terrance KurtenbachExecutive OfficerCanton, CT
William DavisDirectorOakdale, MN
William DavisExecutive OfficerOakdale, MN
Patrick GoraExecutive OfficerAtlanta, GA

Other filings by this issuer (10)

FiledFormOfferingSold
2025-05-19D$60.5M$34.5M
2022-11-09D$14.0M$14.0M
2020-12-23D$16.0M$6.0M
2020-05-01D/A$700K$519K
2019-10-15D$300K$50K
2018-10-29D/A$1.3M$1.3M
2018-05-02D$1.0M$643K
2018-03-28D/A$150K$150K
2018-01-25D$150K$100K
2017-09-11D$300K$225K

More